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Original Research

Rate of Surgery and Baseline Characteristics
Associated With Surgery Progression in
Young Athletes With Prearthritic Hip Disorders
Reid W. Collis,* BS, Andrea B. McCullough,† MD, Chris Ng,‡ MD, MBA, Heidi Prather,§ DO,
Graham A. Colditz,k DrPH, MD, MPH, John C. Clohisy,{ MD, and Abby L. Cheng,§# MD
Investigation performed at Washington University School of Medicine, St. Louis, Missouri, USA
Background: Prearthritic hip disorders (PAHD), such as femoroacetabular impingement (FAI), acetabular dysplasia, and acetabular labral tears, are a common cause of pain and dysfunction in adolescent and young adult athletes, and optimal patientspecific treatment has not been defined. Operative management is often recommended, but conservative management may be a
reasonable approach for some athletes.
Purpose: To identify (1) the relative rate of progression to surgery in self-reported competitive athletes versus nonathletes with
PAHD and (2) baseline demographic, pain, and functional differences between athletes who proceeded versus those who did not
proceed to surgery within 1 year of evaluation.
Study Design: Cohort study; Level of evidence, 3.
Methods: An electronic medical record review was performed of middle school, high school, and college patients who were
evaluated for PAHD at a single tertiary-care academic medical center between June 22, 2015, and May 1, 2018. Extracted variables included patients’ self-reported athlete status, decision to choose surgery within 1 year of evaluation, and baseline selfreported pain and functional scores on Patient-Reported Outcomes Measurement Information System (PROMIS) domains, the Hip
disability and Osteoarthritis Outcome Score (HOOS), and the modified Harris Hip Score.
Results: Of 260 eligible patients (289 hips), 203 patients (78%; 227 hips) were athletes. Athletes were no more likely to choose surgery
than nonathletes (130/227 hips [57%] vs 36/62 hips [58%]; relative risk [RR], 0.99 [95% CI, 0.78-1.25]). Among athletes, those who
proceeded to surgery over conservative care were more likely to be female (81% vs 69%; RR, 1.34 [95% CI, 0.98-1.83]) and had more
known imaging abnormalities (FAI: 82% vs 69%, RR, 1.47 [95% CI, 1.09-1.99]; dysplasia: 48% vs 27%, RR, 1.44 [95% CI, 1.16-1.79];
mixed deformity: 30% vs 10%, RR, 2.91 [95% CI, 1.53-5.54]; known labral tear: 84% vs 40%, RR, 2.79 [95% CI, 2.06-3.76]). Athletes who
chose surgery also reported worse baseline hip-specific symptoms on all HOOS subscales (mean difference, 10.8-17.7; P < .01 for all).
Conclusion: Similar to nonathletes, just over half of athletes with PAHD chose surgical management within 1 year of evaluation.
Many competitive athletes with PAHD continued with conservative management and deferred surgery, but more structural hip
pathology and worse hip-related baseline physical impairment were associated with the choice to pursue surgery.
Keywords: femoroacetabular impingement; acetabular dysplasia; acetabular labral tear; athletes; hip arthroscopy; conservative
management

Prearthritic hip disorders (PAHD) are variations in hip
anatomy that can contribute to chronic pain, disability, and
early hip osteoarthritis (OA) in otherwise healthy adolescents and young adults.10,33 Conditions such as femoroacetabular impingement (FAI), acetabular dysplasia, and
acetabular labral tears are all examples of PAHD, and
these conditions preferentially affect athletes.11,14 A recent
meta-analysis demonstrated that athletes who participate
in sports such as ice hockey, basketball, and other jumping

sports during adolescence have a 1.9- to 8-fold increased
risk of developing a cam deformity during skeletal maturation.31 Labral tears are also particularly common in athletes who participate in sports that involve cutting and
rotation-related movements, 30 with incidence rates of
asymptomatic labral tears as high as 89% in adolescent
skiers and hockey players.5 Furthermore, a high rate of
acetabular dysplasia has been found in ballet dancers.18
The high prevalence of PAHD in athletes may contribute
to the higher prevalence of hip OA in former athletes compared with nonathletes.50
Athletes diagnosed with symptomatic PAHD currently
face a dilemma when choosing a treatment path. They must
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consider both the overall efficacy of the treatment plan and
its impact on returning to sport. Surgical management is
often recommended and can result in relatively good
return-to-sport rates when performed by experienced surgeons. After surgery for FAI, 87% of athletes return to
sport,7 and after periacetabular osteotomy for dysplasia,
80% return to sport and only 7% to 11% report activity
limitations from persistent hip pain.4,20,37 However, the
mean time to return to sport after FAI surgery is 9.4
months,32 and the median return time after periacetabular osteotomy is 9 months.20 These prolonged recovery
times are undesirable for many athletes. Because sports
participation is associated with increased subjective wellbeing13 and because injuries in athletes are known to contribute to emotional distress,25,27,41,45 minimizing time
away from sport should be a consideration in the management of PAHD.
Conservative management typically offers a quicker
return to play than surgical management,35,39 and it has
proven to be effective in some athletes.22 However, athletes
who do not improve sufficiently with an extensive trial of
conservative care and proceed to surgery anyway have an
even more protracted return to play than if they had pursued surgery earlier in their course.22 To our knowledge,
the proportion of competitive athletes who pursue surgery
over continued conservative management is unknown. Furthermore, identification of athlete-specific variables that
are associated with progression to surgery rather than continued conservative management may assist providers in
counseling patients and directing them to appropriate
treatment options that will expedite their recovery and
return to play.
The purpose of this study was 2-fold: (1) to identify the
relative rate of progression to surgery in self-reported competitive athletes versus nonathletes with PAHD and identify unique baseline characteristics associated with being
an athlete, and (2) to identify demographic, pain, and functional differences between athletes who proceed versus do
not proceed to surgery within 1 year of evaluation. We
hypothesized that the high physical demand in athletes
would result in a higher rate of surgery compared with
nonathletes and that athletes who chose surgery would
report worse baseline pain and function compared with
those who continued with conservative care.
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METHODS
This retrospective cohort study was conducted at a single
tertiary-care academic medical center. Institutional review
board approval was granted by the institution.

Patients
Participants included adolescent and young adult patients
aged 13 to 25 years who were initially evaluated by a boardcertified nonoperative sports medicine specialist or orthopaedic surgeon with sports medicine and/or hip preservation
expertise. Patients were included regardless of whether they
had previously been evaluated by other providers at different institutions or with different medical training for the
same issue (such as a primary care physician, physical therapist, and/or athletic trainer). Patients had to report a chief
complaint of hip pain, and the physician documentation had
to state that an intra-articular, nonarthritic hip disorder was
the suspected cause of their symptoms. Eligible structural
diagnoses included cam FAI (ie, reduced femoral head-neck
offset), pincer FAI (ie, acetabular overcoverage), combined
FAI (ie, coexisting cam and pincer morphology), acetabular
dysplasia (ie, acetabular undercoverage), mixed deformity
(ie, coexisting cam FAI and acetabular dysplasia), and acetabular labral tear. Both FAI and dysplasia morphology
were included in this study because the patient populations, clinical evaluations, and initial treatment recommendations often overlap, and the conditions can
commonly coexist. 52 Consistent with previous
effectiveness-focused research in this population,16,38 no
specific quantitative radiographic measurement cutoffs
were required for inclusion.
Because the distinction of “competitive athlete” can
become ambiguous in adult populations who participate
in activities ranging from intramural city leagues to
regional or national club leagues to professional sports, the
eligible cohort for this study was restricted to students in
middle school, high school, and college at the time of initial
evaluation. In this population, competitive athletics can be
defined in a more straightforward fashion, for example
by participation in organized youth or young adult activities such as school-sponsored sports or by participation in
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higher-level competition such as semiprofessional or professional sports.
All initial clinical encounters occurred between June 22,
2015, and May 1, 2018. The start date was chosen to correspond with implementation of Patient-Reported Outcomes
Measurement Information System (PROMIS) measure collection as standard of care for all patients evaluated at our
orthopaedic department. Some of the PROMIS measures
are specifically designed for patients of certain age groups,
so for this study we defined adolescents as being 13 to 17
years old and young adults as patients 18 years and older.
Exclusion criteria included other hip conditions that tend to
initially present in a different patient demographic (eg,
slipped capital femoral epiphysis, Legg-Calvé-Perthes disease, and avascular necrosis), moderate or severe hip OA
(Tönnis grade 2 or 3), prior same-side hip surgery or fracture, prior same-side hip infection or tumor, inflammatory
arthropathy, and pregnancy. Patients whose competitive
athletic status was unknown were also excluded.
Given the observational nature of this study, there was
no predetermined, strict treatment protocol for these
patients. However, all the young adult hip providers at the
study institution follow a relatively standard treatment
protocol that includes an initial trial of conservative management consisting of physical therapy, activity modification, anti-inflammatory medications, and/or intra-articular
hip injections. Patients who do not sufficiently improve
with these conservative measures are offered surgical management if they are deemed appropriate candidates.
Potentially eligible patients were identified via a query of
hip-related billing codes (listed in the Appendix) in patients
aged between 13 and 40 years. This query was performed to
create a comprehensive repository of prearthritic hip
patients evaluated at our institution. Final eligibility for
this study was confirmed with manual chart review by 1
of 3 researchers (R.W.C., A.B.M., or C.N.). Before data
extraction, all 3 researchers underwent standardized training and assessment of appropriate, consistent data interpretation. Questions regarding participant eligibility were
resolved by consultation with the senior author (A.L.C.).

Outcome Measures
The primary outcome measure was the relative rate of progression to surgery at the study institution within 1 year in
self-reported athletes versus nonathletes. (Because the
study was performed at a tertiary referral center with
regional and national recognition for expertise in hip disorders in young adults, it was assumed that the vast majority of patients who proceeded with surgery did so within the
study institution.) Secondary measures included comparison of patient characteristics and baseline self-reported
physical and behavioral health between athletes and nonathletes and, within the athlete cohort, between those who
chose surgery versus those who did not proceed to surgery
within 1 year of evaluation.
The following self-reported descriptive variables were
recorded: patient demographics (age, sex, race, and grade
level); body mass index; baseline activity level as measured
by the University of California Los Angeles (UCLA) Activity
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Score (scored from 1 [wholly inactive] to 10 [regularly active
in impact sports]); history of depression and/or low back
pain; hip pain duration; participation in competitive sports;
number of and which sports were played; and the physiciandocumented PAHD diagnosis. Patients who endorsed
involvement in competitive sports were considered athletes,
while those who did not were considered nonathletes. For
the majority of patients, competitive athlete status was
determined by their answers on a standard-of-care form that
systematically inquires about their athletic participation in
organized sports. Because “being an athlete” is accompanied
by unique psychological identity traits compared with being
a person who is “physically active,”21 we felt that patients’
self-reported athlete status was the best method to capture
this construct. For the patients who were evaluated by physicians who did not routinely collect this form, athlete status
was determined by review of the clinical notes. With the
exception of the UCLA score, all descriptive variables were
recorded as part of standard clinical care for all included
patients. The UCLA score was only routinely collected in
select circumstances, as described below.
When available, baseline patient-reported outcome measures (PROMs) were also recorded (Table 1). These
included the modified Harris Hip Score (mHHS), the Hip
disability and Osteoarthritis Outcome Score (HOOS), and
physical and behavioral health domains from PROMIS.
Both the mHHS and the HOOS are hip-specific measures
that are scored from 0 to 100, with higher scores being
favorable. 19,34 PROMIS consists of multiple health
domains, each of which is normalized to a mean score of
50 and standard deviation of 10 in the general population.
Higher scores represent more of the specific domain being
tested.6 PROMIS computer-adaptive test measures were
collected as part of standard clinical care. The PROMIS
Physical Function domain encompasses both upper and
lower body function, while the Mobility domain focuses
exclusively on lower body function. The Depression and
Anxiety measurements were not assessed in pediatric
patients due to concern for potential psychological distress
associated with answering the questions. The Peer Relationships domain was chosen as a proxy for pediatric psychosocial health.
Of note, at this institution during the study period, the
UCLA score, mHHS, and HOOS measures were only completed as standard of care by patients who had scheduled
surgery with any hip surgeon or if they were evaluated by
the senior hip preservation surgeon (J.C.C.), regardless of
whether they pursued surgery or not. Furthermore, the
PROMIS Anxiety domain was not routinely collected until
10 months after the study start date, and the adult PROMIS Mobility domain was only collected from patients who
were evaluated by surgeons. Therefore, some PROM data
were preferentially missing from patients who continued
conservative management because of the administrative
limitations of this retrospective study.

Statistical Analysis
Descriptive variables are reported as means and standard
deviations for continuous data and frequency and
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TABLE 1
Baseline Patient-Reported Outcome Measures Recordeda
Adult PROMIS CATb
Depression V 1.0
Anxiety V 1.0c
Pain Interference V 1.1
Physical Function V 1.2 or V 2.0
Mobility V 1.2d
Pediatric PROMIS CATb
Peer Relationships V 2.0
Pain Interference V 2.0
Mobility V 2.0
mHHSe
HOOSe
Symptoms
Pain
ADL
Sports
QoL
a
ADL, Activities of Daily Living; CAT, computer adaptive test;
HOOS, Hip disability and Osteoarthritis Outcome Score; mHHS,
modified Harris Hip Score; PROM, patient-reported outcome
measure; PROMIS, Patient-Reported Outcomes Measurement
Information System; QoL, Quality of Life.
b
Adult PROMIS CAT measures were collected from patients
18 years of age and older. Pediatric PROMIS measures were
collected from patients younger than 18 years.
c
PROMIS Anxiety was not routinely collected until 10 months
after the study start date.
d
Adult PROMIS Mobility was only collected from patients
who were evaluated by surgeons.
e
The mHHS and HOOS PROMs were only completed as standard of care by patients who scheduled surgery with any hip
surgeon or if they were evaluated by the senior hip preservation
surgeon.

percentages for categorical data. The primary outcome was
calculated as a relative risk (RR) with a 95% CI. In patients
who were evaluated for bilateral hip pain (either at a single
encounter or over 2 separate encounters), each hip was
considered individually because progression to surgery is
specific to each hip. Additionally, a multilevel multiple
logistic regression was performed to assess the association
between athlete status and progression to surgery when
controlling for age, sex, hip morphology (ie, presence of FAI
or acetabular dysplasia), and the instances of bilateral hip
pain. Regarding the secondary measures, differences in
continuous variables (between athletes versus nonathletes
and between surgical versus nonsurgical patients among
the athlete cohort) were assessed using unpaired t tests,
and mean differences (MDs) with 95% CIs are reported.
Differences in categorical variables were evaluated using
chi-square tests or Fisher exact tests, as indicated, and the
RR with a 95% CI is reported. Because 1 primary outcome
was prespecified and the rest of the comparisons were
exploratory secondary outcomes, no multiple-comparison
adjustment was performed. Missing data are listed in the
tables shown in the Results section. P  .05 was prespecified to represent statistical significance. All statistical analyses were performed using SAS software, Version 9.4.
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RESULTS
Of the 1476 potential participants identified from the initial
billing query, 260 middle school, high school, and college
students (289 hips) with confirmed PAHD were eligible for
this study (Figure 1). Of these, 203 patients (78%; 227 hips)
were athletes. Running-related sports were the most commonly reported activity, followed closely by dance, soccer,
and baseball/softball (Table 2).

Athletes Versus Nonathletes
Athletes were no more likely than nonathletes to choose
surgery within 1 year of evaluation (130/227 hips [57%] vs
36/62 hips [58%], respectively; RR, 0.99 [95% CI 0.78-1.25];
P ¼ .91) (Table 3). Even after controlling for age, sex, presence of FAI and dysplasia, and bilateral symptoms, 2-level
multiple logistic regression did not demonstrate a statistically significantly increased surgical rate in athletes (OR,
1.20 [0.57-2.55]; P ¼ .62). However, there were other demographic differences between the 2 cohorts. Compared with
nonathletes, the athlete cohort was younger (17.1 vs 19.2
years; P < .001) and more likely to be in middle school or
high school instead of college (80% vs 33%; P < .001). The
athlete cohort also had relatively fewer female patients
(75% vs 91%; P ¼ .01), and on average, athletes were evaluated after a shorter symptom duration (56% vs 32% within
1 year; P < .001). Regarding hip morphology, athletes were
more likely to have a diagnosis of FAI (77% vs 56%; P ¼
.002) and were less likely to have acetabular dysplasia (39%
vs 63%; P ¼ .001). The prevalence of known labral tears was
similar between groups (57% vs 58%; P ¼ .74).
Regarding self-reported physical health, athletes
reported less overall pain interference compared with
nonathletes (Adult PROMIS Pain Interference, MD ¼
2.9 points; P ¼ .017; and Pediatric PROMIS Pain Interference, MD ¼ 4.1 points, P ¼ .034), but there was no
statistically significant difference in hip-specific symptoms or function as measured by the mHHS or HOOS
subscales (Table 4). Adult athletes also reported better
overall physical function (Adult PROMIS Physical Function, MD ¼ –3.0 points; P ¼ .018), but lower body mobility
was not different in adolescent or adult athletes versus
nonathletes. Regarding behavioral health, athletes had a
much lower prevalence of self-reported history of depression (4% vs 28%; P < .001), but the between-group differences in Adult PROMIS Depression and Anxiety scores at
initial evaluation did not reach statistical significance. Of
note, because the majority of eligible participants were
younger than 18 years, the sample size for Adult PROMIS
measures was limited.

Progression to Surgery in Athletes
Among the athlete cohort, the surgical group was more
female predominant (81% vs 69%; P ¼ .045), had suffered
from hip pain for a somewhat longer duration (73% vs 58%
with pain longer than 6 months; P < .001), and had a higher
prevalence of radiographic FAI (82% vs 69%; P ¼ .020) and
acetabular dysplasia (48% vs 27%; P ¼ .001), especially in
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Identified in billing query
N=1476

Confirmed to have PAHD
on manual chart review
n=715 (815 hips)

Middle school, high school, and
college students
n=297 (351 hips)

Competitive athlete status known
n=260 (289 hips)

Nonathletes
n=57 (62 hips)

Pursued surgery
n=35 (36 hips)

Athletes
n=203 (227 hips)

Did not pursue surgery
n=22 (26 hips)

Pursued surgery
n=124 (130 hips)

Did not pursue surgery
n=90 (97 hips)

Figure 1. Participant inclusion flowchart. PAHD, prearthritic hip disorder.
TABLE 2
Competitive Sports Participation Among Middle School,
High School, and College Students Evaluated
Between 2015 and 2018a
n (%)
Number of Sports (n ¼ 260)
0
1
2
3
4
Sport played (n ¼ 203)
Running (track/cross-country)
Dance
Soccer
Baseball/softball
Basketball
Volleyball
Cheer
Football
Swimming
Lacrosse
Field hockey
Tennis
Gymnastics

57 (22)
123 (47)
52 (20)
24 (9)
4 (2)
53 (26)
44 (22)
32 (16)
32 (16)
27 (13)
21 (10)
20 (10)
15 (7)
14 (7)
10 (5)
5 (2)
5 (2)
5 (2)

a
Because some athletes played multiple sports, the sum of percentages of athletes involved in each sport exceeds 100%. Competitive sports that were reported in <5 participants are not listed.

the presence of a diagnosed acetabular labral tear (84% vs
40%; P < .001). Coexisting (mixed) FAI and dysplasia deformity was also more common in the surgical group (30% vs
10%; P ¼ .001). Other participant demographics were similar between those who did and did not proceed with surgery (Table 5).

Compared with athletes who did not pursue surgery
within one year, athletes who progressed to surgery
reported worse hip dysfunction on all 5 HOOS subscales
(MD ¼ 10.8-17.7; all P < .01) but not on the mHHS (Table 6).
Furthermore, among adolescent athletes (age <18 years),
the surgical group reported worse pain interference and
lower body mobility on PROMIS measures, as well (Pediatric PROMIS Pain Interference, MD ¼ –4.7 points; P < .001;
and Pediatric PROMIS Mobility, MD ¼ 4.9 points; P <
.001). Regarding behavioral health, there was no
between-group difference in self-reported history of depression at initial evaluation. There were also no statistically
significant between-group differences on any of the Adult
PROMIS measures, but again, the sample size for this older
group of athletes was limited.

DISCUSSION
Contrary to our hypothesis, in this study of students evaluated with hip pain due to PAHD, athletes were no more
likely than nonathletes to choose surgical intervention
within one year of evaluation. This finding remained true
even after controlling for age, sex, presence of FAI and/or
acetabular dysplasia, and presence of bilateral hip symptoms. In fact, only 58% of athletes opted for surgery. Athletes reported similar hip-specific symptom severity to
nonathletes, but athletes experienced less overall pain
interference and had a lower prevalence of preexisting
depression. Within the athlete cohort, longer symptom
duration, more evidence of structural abnormalities, and
worse self-reported hip symptoms and overall physical
function were associated with their choice to pursue surgery. There was no definitive difference in behavioral
health between the surgical and nonsurgical groups.
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TABLE 3
Clinical Characteristics and Choice to Pursue Surgery in Athletes Versus Nonathletesa

Age, y
Female sex
Race
White
Black
Asian
Hispanic/Latino
Grade level
Middle school
High school
College
UCLA Activity Scoreb
BMIc
Depressiond
Low back paine

Hip pain duration
<6 mo
6 to 12 mo
1 to 3 y
3 to 5 y
>5 y
Hip pathology
FAI
Cam
Pincer
Combined
Unknown subtype
FAI þ labral tear f
Acetabular dysplasia
Dysplasia þ labral tear f
Mixed (FAI þ dysplasia)
(Known) labral tear
Chose surgery

Athletes (n ¼ 203)

Nonathletes (n ¼ 57)

RR (95% CI)

MD (95% CI)

P Value

17.1 ± 2.2
153 (75)

19.2 ± 2.9
52 (91)

—
0.82 (0.73 to 0.92)

2.2 (1.3 to 3.0)
—

<.001
.010
.505

192 (95)
6 (3)
3 (1)
2 (1)

53 (93)
3 (5)
0 (0)
1 (2)

19 (9)
145 (71)
39 (19)
7.9 ± 2.6
23.0 ± 3.7
8 (4)
28 (15)

3 (5)
16 (28)
38 (67)
5.7 ± 2.7
23.6 ± 4.5
15 (28)
9 (17)

Athlete Hips (n ¼ 227)

Nonathlete Hips (n ¼ 62)

76 (33)
52 (23)
66 (29)
21 (9)
12 (5)

8 (13)
12 (19)
18 (29)
14 (23)
10 (16)

2.59
1.18
1.00
0.41
0.33

(1.32 to
(0.68 to
(0.65 to
(0.22 to
(0.15 to

5.08)
2.07)
1.55)
0.76)
0.72)

174 (77)
128 (56)
13 (6)
6 (3)
27 (12)
117 (52)
88 (39)
56 (25)
49 (22)
148 (65)
130 (57)

35 (56)
25 (40)
2 (3)
1 (2)
7 (11)
24 (39)
39 (63)
23 (37)
17 (27)
39 (63)
36 (58)

1.36
1.40
1.78
1.64
1.05
1.33
0.62
0.67
0.79
1.04
0.99

(1.08 to
(1.01 to
(0.41 to
(0.20 to
(0.48 to
(0.95 to
(0.48 to
(0.45 to
(0.49 to
(0.84 to
(0.78 to

1.71)
1.93)
7.66)
13.36)
2.30)
1.87)
0.79)
0.99)
1.27)
1.28)
1.25)

1.02
0.56
2.00
0.56

(0.94 to
(0.14 to
(0.10 to
(0.05 to

1.10)
2.18)
37.98)
6.08)

—
—
—
—
<.001

1.78 (0.55 to 5.80)
2.54 (1.66 to 3.89)
0.29 (0.21 to 0.40)
—
—
0.14 (0.06 to 0.31)
0.90 (0.45 to 1.80)

—
—
—
–2.2 (–3.1 to –1.3)
0.7 (–0.5 to 1.8)
—
—

<.001
.271
<.001
.773

<.001
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—

.002

.097
.001
.043
.323
.738
.911

a
Continuous variables are reported as mean ± SD, and categorical variables are reported as n (%). Comparisons between athletes and
nonathletes are reported as relative risk (RR) for categorical variables and mean difference (MD) for continuous variables. Boldface P values
indicate a statistically significant difference between groups. Dashes indicate not applicable. BMI, body mass index; FAI, femoroacetabular
impingement; UCLA, University of California, Los Angeles.
b
Athletes, n ¼ 107; nonathletes, n ¼ 40.
c
Athletes, n ¼ 202; nonathletes, n ¼ 57.
d
Athletes, n ¼ 201; nonathletes, n ¼ 54.
e
Athletes, n ¼ 186; nonathletes, n ¼ 54.
f
Patients with FAI, dysplasia, and a known labral tear are represented in both the “FAI þ labral tear” and “Dysplasia þ labral tear” counts.

Our results build on the findings by Hunt et al,22 in which
patients with PAHD completed a standardized conservative
management protocol and then were given the option of surgical management if their symptoms were not controlled.
Similar to our results, the cohort was predominantly female,
and only 56% of those patients chose to have surgery. However, in that prospective study, patients who were more
active were more likely to choose surgery, whereas in our
cohort, competitive athletes were no more likely to proceed
to surgery than nonathletes, and the athletes who proceeded
to surgery reported similar activity levels to the athletes who
continued with conservative care. One potential reason for

the discrepancy between the two studies is that our cohort
was younger than the Hunt et al cohort (mean age, 17 vs 35
years), and younger active people are likely more involved in
organized, competitive sports during their school-aged
years, whereas older active adults may more often engage
in independent fitness activities.1,49 Our findings yield new
insights because participation in competitive sports involves
external psychosocial pressures21 often linked to injury,3,40
which makes competitive athletes a unique population distinct from generally active people. Athletes involved in competitive sports have been found to have better pain coping
strategies and less pain catastrophization than
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TABLE 4
Self-Reported Baseline Health in Athletes Versus Nonathletesa
Athletes (n ¼ 203)
Adult PROMISb
Depression
Anxiety
Pain Interference
Physical Function
Mobility
Pediatric PROMISb
Peer Relationships
Pain Interference
Mobility
mHHSc
HOOSc
Symptoms
Pain
ADL
Sports
QoL

44.9
48.2
59.2
43.8
44.4

±
±
±
±
±

8.4
9.7
5.2
5.5
6.6

54.4
55.9
38.1
62.8

±
±
±
±

53.9
57.6
70.8
44.2
36.4

±
±
±
±
±

Nonathletes (n ¼ 57)

MD (95% CI)

P Value

Athletes/Nonathletes, n

48.2
52.6
62.0
40.7
41.7

± 10.5 (44.7 to 51.7)
± 10.8 (48.2 to 57.0)
± 6.1 (60.0 to 64.1)
± 6.5 (38.6 to 42.9)
± 8.3 (36.9 to 46.4)

3.3 (–0.6 to 7.2)
4.4 (–0.8 to 9.6)
2.9 (0.5 to 5.2)
–3.0 (–5.5 to –0.5)
–2.7 (–7.9 to 2.5)

.098
.097
.017
.018
.298

56/37
38/25
56/37
56/37
20/14

9.6 (52.7 to 56.1)
7.5 (54.6 to 57.2)
7.1 (36.8 to 39.3)
14.2 (60.1 to 65.5)

55.1
60.0
36.1
58.0

± 9.4 (50.3 to 60.0)
± 6.4 (56.7 to 63.3)
± 6.8 (32.6 to 39.6)
± 14.0 (53.5 to 62.5)

0.8 (–4.1 to 5.7)
4.1 (0.3 to 7.8)
–2.0 (–5.6 to 1.6)
–4.8 (–10.0 to 0.4)

.758
.034
.275
.070

122/17
125/17
125/17
107/40

17.8 (50.5
18.6 (54.0
19.0 (67.1
22.9 (39.8
19.6 (32.6

50.9
52.8
65.3
38.7
32.5

± 23.1
± 21.4
± 22.8
± 27.2
± 20.8

–3.1 (–11.1
–4.8 (–11.9
–5.4 (–12.8
–5.5 (–14.4
–3.9 (–11.2

.451
.185
.146
.220
.299

107/40
107/40
107/40
106/40
107/40

(42.6 to
(45.0 to
(57.8 to
(42.3 to
(41.3 to

47.1)
51.4)
60.5)
45.2)
47.4)

to 57.4)
to 61.1)
to 74.4)
to 48.6)
to 40.1)

(43.5 to
(45.9 to
(58.0 to
(30.0 to
(25.9 to

58.3)
59.6)
72.6)
47.4)
39.1)

to
to
to
to
to

5.0)
2.3)
1.9)
3.3)
3.5)

a
Variables are reported as mean ± SD (95% CI). Bolded P values indicate a statistically significant difference between groups. ADL,
Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MD, mean difference; mHHS, modified Harris Hip Score;
PROM, patient-reported outcome measure; PROMIS, Patient-Reported Outcomes Measurement Information System; QoL, Quality of Life.
b
In total, 97 patients (59 athletes, 38 nonathletes) were 18 years of age and met criteria to complete the Adult PROMIS measures, and
163 patients (144 athletes, 19 nonathletes) were <18 years of age and met criteria to complete the Pediatric PROMIS measures.
c
The mHHS and HOOS PROMs were only completed as standard of care by patients who scheduled surgery with any hip surgeon or if they
were evaluated by the senior hip preservation surgeon.

nonathletes, 12,47 which may explain why the athletes
reported in our study reported similar levels of hip pain
severity to the nonathletes but less interference in their
daily lives from their symptoms. Furthermore, the opportunity to participate in school-sponsored competitive athletics
is only possible during a limited timeframe (even in the
absence of injury), so these young competitive athletes may
be more likely than otherwise active adults to defer surgery
in order to finish a sports season or career. In contrast, active
adults may have completed their competitive careers and
have had pain for a longer duration, which may sway them
to pursue surgery if their symptoms have not adequately
been controlled with conservative measures.
Our statistically significant mean score differences
approximated or exceeded previously published minimal
clinically important differences (MCIDs) for all reported
PROMs, which are summarized in Table 7. This suggests
that the significant PROM differences in this study are
consistent with clinically meaningful findings. Of course,
comparison of our findings with previously determined
MCIDs should still be interpreted with caution because
some of the MCIDs were calculated in patients with other
medical conditions,2,8,26,28,36,48 and although the published
mHHS and HOOS MCIDs were calculated in patients with
hip pain, those patients had all undergone hip arthroscopy,
whereas many patients in our cohort did not.24
Self-reported baseline behavioral health reported by the
athletes and nonathletes in our study is also notable.
Although our athlete cohort consisted of significantly fewer
individuals with a self-reported history of depression than

the nonathlete cohort, a previous meta-analysis found
depressive symptoms to be similar in high-performance athletes and nonathletes,15 and other evidence has demonstrated a high frequency of depression in athletes after
injury.25,27,41,45 However, other literature suggests that athletes may be more likely to ignore depressive symptoms17,42,44,51 and may be more adept at dealing with
them.23 It is possible that the interplay between these two
phenomena contributed to the trend of lower rates of selfreported behavioral health impairment reported in the
athlete subgroup of our study. Nevertheless, baseline
depression and anxiety are associated with worse pre- and
postoperative hip function (specifically after hip arthroscopy),9,46 so we still advocate for screening for current or
prior psychological impairment. When appropriate, guiding
affected patients to resources for behavioral health management can be incorporated as part of a conservative management plan or for preoperative optimization.43

Strengths
Unlike most of the existing PAHD literature, this study
included patients who were evaluated by both operative
and nonoperative sports medicine specialists, and the study
population included patients who both chose and did not
choose to proceed to surgery. The operative and nonoperative specialists at this institution follow a relatively standard treatment protocol, as described in the Methods
section. However, patients who choose to be evaluated by
operative versus nonoperative specialists may have

8

Collis et al

The Orthopaedic Journal of Sports Medicine

TABLE 5
Clinical Characteristics in Athletes Based on Decision to Pursue Hip Surgerya

Age, y
Female sex
Race
White
Black
Asian
Hispanic/Latino
Grade level
Middle school
High school
College
UCLA Activity Scoreb
BMIc
Depressiond
Low back paine
Hip pain duration
<6 mo
6 to 12 mo
1 to 3 y
3 to 5 y
>5 y
Hip pathology
FAI
Cam
Pincer
Combined
Unknown subtype
FAI þ labral tearf
Acetabular dysplasia
Dysplasia þ labral tearf
Mixed (FAI þ dysplasia)
(Known) labral tear

Surgical Hips (n ¼ 130)

Nonsurgical Hips (n ¼ 97)

RR (95% CI)

MD (95% CI)

17.1 ± 2.1
105 (81)

16.8 ± 2.4
67 (69)

—
1.34 (0.98 to 1.83)

–0.3 (–0.9 to 3.0)
—

124 (95)
3 (2)
2 (2)
1 (1)

90 (93)
5 (5)
1 (1)
1 (1)

11 (8)
92 (71)
27 (21)
7.6 ± 2.7
23.2 ± 3.6
7 (5)
21 (17)

12 (12)
69 (71)
16 (16)
8.4 ± 2.2
22.7 ± 3.7
4 (4)
10 (12)

35 (27)
34 (26)
42 (32)
12 (9)
7 (5)

41 (42)
18 (19)
24 (25)
9 (9)
5 (5)

0.64
1.41
1.31
0.99
1.04

(0.44 to
(0.85 to
(0.85 to
(0.44 to
(0.34 to

0.92)
2.34)
2.00)
2.27)
3.19)

107 (82)
78 (60)
2 (2)
12 (9)
15 (12)
95 (73)
62 (48)
43 (33)
39 (30)
109 (84)

67 (69)
50 (52)
4 (4)
1 (1)
12 (12)
22 (23)
26 (27)
13 (13)
10 (10)
39 (40)

1.47
1.16
0.37
8.95
0.93
3.22
1.44
2.47
2.91
2.79

(1.09 to
(0.92 to
(0.07 to
(1.18 to
(0.46 to
(2.20 to
(1.16 to
(1.41 to
(1.53 to
(2.06 to

1.99)
1.48)
2.00)
67.70)
1.90)
4.72)
1.79)
4.33)
5.54)
3.76)

1.03
0.45
1.49
0.75

(0.96 to
(0.11 to
(0.14 to
(0.05 to

1.10)
1.83)
16.22)
11.78)

P Value
.355
.045
.700

—
—
—
—
.503

0.68 (0.32 to 1.48)
0.99 (0.84 to 1.18)
1.26 (0.72 to 2.20)
—
—
1.28 (0.38 to 4.23)
1.42 (0.70 to 2.83)

—
—
—
0.8 (–0.3 to 1.9)
–0.5 (–1.5 to 0.5)
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—

.138
.308
.762
.334
<.001

.020

<.001
.001
.002
.001
<.001

a
Continuous variables are reported as mean ± SD, and categorical variables are reported as n (%). Comparisons between the surgical and
nonsurgical groups are reported as relative risk (RR) for categorical variables and mean difference (MD) for continuous variables. Boldface P
values indicate a statistically significant difference between groups. Dashes indicate not applicable. BMI, body mass index; FAI, femoroacetabular impingement; UCLA, University of California, Los Angeles.
b
Surgery, n ¼ 83; no surgery, n ¼ 32.
c
Surgery, n ¼ 129; no surgery, n ¼ 94.
d
Surgery, n ¼ 129; no surgery, n ¼ 96.
e
Surgery, n ¼ 124; no surgery, n ¼ 83.
f
Patients with FAI, dysplasia, and a known labral tear are represented in both the “FAI þ labral tear” and “Dysplasia þ labral tear” counts.

inherently different treatment preferences, and the specialty training backgrounds of specialists may influence the
evaluation and management of patients in ways that have
not yet been thoroughly studied. Therefore, our patient
population likely provides a closer representation of the full
spectrum of patients with PAHD than previous observational studies that have reported only on patients who have
undergone surgery with nationally and internationally recognized hip preservation surgeons.

Limitations
Because this study was performed at a single tertiary-care
institution, there is likely still some bias in the population of
patients with PAHD who were evaluated. While some
patients came for their first evaluation of hip pain, others

chose to come or were referred for a second or third opinion
regarding PAHD management. Therefore, our PAHD surgical rate may still be an overestimate compared with all adolescents and young adults who come to a physician for a first
evaluation of hip pain related to a PAHD. A second limitation is that, because of the departmental workflow, some
PROMs were disproportionately completed by patients who
were initially evaluated by surgeons rather than nonoperative specialists. This was a known limitation from the outset
of the study, but because PROM data in nonsurgical patients
with PAHD are scant in the existing literature, we felt the
analyses were worth pursuing and could still provide valuable insight as exploratory findings. Still, our study may
have been underpowered to detect between-group differences in some of the secondary outcomes. Third, competitive
athlete status was unknown in a small proportion of
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TABLE 6
Self-Reported Baseline Health in Athletes Based on Decision to Pursue Surgerya
Surgical Hips (n ¼ 130)
Adult PROMIS
Depression
Anxiety
Pain Interference
Physical Function
Mobility
Pediatric PROMIS
Peer Relationships
Pain Interference
Mobility
mHHS
HOOS
Symptoms
Pain
ADL
Sports
QoL

Nonsurgical Hips (n ¼ 97)

44.2
48.4
60.3
42.9
44.9

± 7.6 (41.6 to 46.8)
± 10.1 (44.0 to 52.9)
± 5.1 (58.6 to 62.0)
± 6.0 (41.0 to 44.8)
± 7.4 (40.6 to 49.2)

45.3
47.8
58.0
44.4
43.0

± 9.3
± 9.3
± 5.0
± 5.5
± 4.4

52.8
58.3
35.8
61.9

± 9.7 (50.6 to 55.0)
± 5.5 (57.1 to 59.6)
± 4.9 (34.7 to 36.9)
± 14.1 (58.8 to 65.0)

56.0
52.9
40.6
66.4

51.4
54.8
68.5
40.5
33.7

± 16.4
± 16.7
± 17.9
± 21.1
± 18.6

62.3
67.3
79.3
58.1
45.8

(47.8 to
(51.2 to
(64.6 to
(35.8 to
(29.6 to

55.0)
58.5)
72.4)
45.1)
37.8)

(41.7
(43.4
(56.0
(42.3
(38.5

to 48.9)
to 52.1)
to 59.9)
to 46.5)
to 47.6)

MD (95% CI)

1.1
–0.7
–2.3
1.5
–1.9

(–3.1 to
(–6.7 to
(–4.9 to
(–1.3 to
(–8.7 to

± 9.1 (53.6 to 58.3)
± 8.4 (50.7 to 55.1)
± 8.5 (38.4 to 42.8)
± 14.2 (61.2 to 71.6)

3.2
–5.5
4.8
4.5

± 18.8
± 21.2
± 19.7
± 24.0
± 21.6

10.8
12.5
10.8
17.7
12.1

(55.4 to
(59.5 to
(72.1 to
(49.2 to
(37.8 to

69.2)
75.1)
86.5)
67.1)
53.7)

5.3)
5.4)
0.2)
4.3)
5.0)

P Value

Surgery/No Surgery, n

.608
.827
.073
.298
.572

28/36
20/22
36/28
36/28
14/6

(–0.1 to 6.4)
(–7.9 to –3.0)
(2.3 to 7.2)
(–1.4 to 10.4)

.055
<.001
<.001
.135

77/59
80/59
80/59
82/31

(3.7 to
(4.9 to
(3.1 to
(8.4 to
(3.9 to

.003
.001
.006
<.001
.004

82/31
82/31
82/31
82/30
82/31

18.0)
20.0)
18.5)
26.9)
20.2)

a
Variables are reported as mean ± SD (95% CI). Boldfaced P values indicate a statistically significant difference between groups. ADL,
Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MD, mean difference; mHHS, modified Harris Hip Score;
PROMIS, Patient-Reported Outcomes Measurement Information System; QoL, Quality of Life.

TABLE 7
Mean Differences in PROMs Between Patient Subgroups in This Study Compared With Published MCIDsa
Athletes vs Nonathletes
Adult PROMIS
Depression
Anxiety
Pain Interference
Physical Function
Mobility
Pediatric PROMIS
Peer Relationships
Pain Interference
Mobility
mHHS
HOOS
Symptoms
Pain
ADL
Sports
QoL

Athletes: Surgery vs No Surgery

3.3 (–0.6 to 7.2)
4.4 (–0.8 to 9.6)
2.9 (0.5 to 5.2)
–3.0 (–5.5 to –0.5)
–2.7 (–7.9 to 2.5)

1.1 (–3.1
–0.7 (–6.7
–2.3 (–4.9
1.5 (–1.3
–1.9 (–8.7

0.8 (–4.1 to 5.7)
4.1 (0.3 to 7.8)
–2.0 (–5.6 to 1.6)
–4.8 (–10.0 to 0.4)

3.2 (–0.1 to 6.4)
–5.5 (–7.9 to –3.0)
4.8 (2.3 to 7.2)
4.5 (–1.4 to 10.4)

–3.1
–4.8
–5.4
–5.5
–3.9

10.8
12.5
10.8
17.7
12.1

(–11.1
(–11.9
(–12.8
(–14.4
(–11.2

to
to
to
to
to

5.0)
2.3)
1.9)
3.3)
3.5)

(3.7
(4.9
(3.1
(8.4
(3.9

to 5.3)
to 5.4)
to 0.2)
to 4.3)
to 5.0)

to
to
to
to
to

MCID

2
2.3
2
1.9

to 3.1
to 3.4
to 5
to 2.2
—

2.0 to 3.0
2.0 to 3.0
2.0 to 3.0
8

18.0)
20.0)
18.5)
26.9)
20.2)

9
9
6
10
11

MCID Reference Population
Chronic MSK pain,26 knee OA28
Knee OA28
Depression,2 back pain,8 knee OA28
Knee OA28

Nephrotic syndrome36,48
Nephrotic syndrome36,48
Nephrotic syndrome36,48
Hip arthroscopy29
Hip arthroscopy29
Hip arthroscopy29
Hip arthroscopy29
Hip arthroscopy29
Hip arthroscopy29

a
Variables are reported as mean difference (95% CI). Boldfaced mean differences indicate statistical significance. —, no MCID has been
published for adult PROMIS mobility. ADL, Activities of Daily Living; HOOS, Hip disability and Osteoarthritis Outcome Score; MCID,
minimal clinically important difference; mHHS, modified Harris Hip Score; MSK, musculoskeletal; OA, osteoarthritis; PROMIS, PatientReported Outcomes Measurement Information System; QoL, Quality of Life.

patients, which necessitated their exclusion from the study.
Finally, this study does not elucidate why only the minority
of athletes had bilateral symptoms even though PAHDs are
known to preferentially affect athletes. One possible explanation is that hand dominance and asymmetric daily activities (such as driving) predispose athletes to move with
asymmetric mechanics even during seemingly symmetric,
reciprocal-type activities such as running. Further dedicated
study is needed in order to understand this phenomenon.

CONCLUSION
In this retrospective study of adolescents and young adults
who were evaluated with hip pain from PAHD, just over
half of both self-reported competitive athletes and nonathletes chose surgery within one year, and athletes were no
more likely than nonathletes to proceed to surgery within
that timeframe. Furthermore, an athlete’s progression to
surgery was associated with worse baseline physical
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function and hip-related quality of life, but choice for surgery was not associated with worse psychological distress.
These findings provide preliminary evidence that conservative management may be an acceptable option for some
athletes, especially those with less structural hip pathology
and less severe hip-related baseline physical impairment.
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APPENDIX
Billing codes used in electronic medical record
query for potentially eligible participants.
International Classification of Diseases, Ninth Revision codes:
719.45: Pain in joint, pelvic region, and thigh
719.85: Other specified disorders of joint, pelvic region, and
thigh
754.3: Congenital dislocation of hip
755.63: Other congenital deformity of hip (joint)
International Classification of Diseases, Tenth Revision codes:
M25.551: Pain in right hip
M25.552: Pain in left hip
M25.559: Pain in unspecified hip
M25.851: Other specified joint disorders, right hip
M25.852: Other specified joint disorders, left hip
M25.859: Other specified joint disorders, unspecified hip
M76.892: Other specified enthesopathies of left lower limb,
excluding foot
Q65.2: Congenital dislocation of hip, unspecified
Q65.89: Other specified congenital deformities of hip
Z87.76: Personal history of (corrected) congenital malformations of integument, limbs, and musculoskeletal
system
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